Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine

American Heart Journal

Volumn 132, Issue 5, 1996, Pages 959-963

  Ishihara, Masaharu ^a,b   Sato, Hikaru ^a,b   Tateishi, Hironobu ^a,b   Kawagoe, Takuji ^a,b   Shimatani, Yuji ^a,b   Kurisu, Satoshi ^a,b   Sakai, Kazuko ^a,b  

^a Hiroshima City Hospital ^*

^b HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY REPERFUSION; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029807005     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90005-8     Document Type: Article

References (22)

1. Sato H, Yamagata T, Sueda T, Nunobiki T, Tateishi H, Sasaki K. Effects of intracoronary thrombolysis therapy on left ventricular function after acute myocardial infarction. Jpn Circ J 1985;49:616-26.
2. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
3. Kloner RA, Gantone CE, Jennings RB. The "uo-reflow" phenomenon after temporary coronary occlusion in dog. J Clin Invest 1974;54:1496-508.
4. Kitazume H, Iwama T, Kubo I, Ageishi Y, Suzuki A. No-reflow phenomenon during percutaneous transluminal coronary angioplasty. Am Heart J 1988;116:211-5.
5. Feld H, Lichstein E, Schachter J, Shani J. Early and late angiographic findings of "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. Am Heart J 1992;123:782-4.
6. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995; 130:239-43.
7. Wilson RT, Shite CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious human. Circulation 1986;73:444-51.
8. Ishihara M, Sato H, Tateishi H, Kawagoe T, Yoshimura M, Muraoka Y. Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction. Br Heart J 1993;69:288-92.
9. The TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985;312:932-6.
10. Ishihara M, Sato H, Tateishi H, Uchida T, Dote K. Intraaortic balloon pumping as the post-angioplasty strategy in acute myocardial infarction. Am Heart J 1991;122:385-9.
11. Gibson CM, Cannon CP, Piana RN, Maher KA, Davis SP, Breall JA, et al. for the TIMI 4 Study Group. Relationship of coronary flow to myocardial infarction size: two simple methods to sub-classify TIMI flow grades. Circulation 1992;86:I-453.
12. Ames A III, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia II: the no-reflow phenomenon. Am J Pathol 1968;52:437-53.
13. Johnson WB, Malone SA, Pantely GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988;78:462-72.
14. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
15. Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the "no-reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985;5:593-8.
16. Armiger LC, Gavin JB. Changes in the microvasculature of ischemic and infarcted myocardium. Lab Invest 1975;33:51-6.
17. Engler RE, Schmid-Schonheim GW, Pavelee RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
18. Folts JD, Crowell EB Jr, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976;54:365-70.
19. Hellstrom HR. The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease: resistance vessel-spasm hypothesis of ischemic disease. Am J Cardiol 1982;49:802-10.
20. Piana PN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994;89:2514-8.
21. Chew CYC, Hecht HS, Collett JT, McAllister RG, Singh BN. Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol 1981;47:917-22.
22. Babbitt DG, Virmani R, Forman MB. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 1989;80:1388-99.